This forum contains news that Pancreatic Cancer UK and forum users have shared over the years.
PressWatch
Posts: 42
Joined: Thu Mar 25, 2010 5:31 pm

Innovative treatment goes into Phase II trial in US

Postby PressWatch » Mon Aug 02, 2010 6:47 pm

Infinity Pharmaceuticals (a smallish biotech company in Cambridge, Massachussetts) has a compound - IPI-926 - which, combined with gemcitabine, is going into Phase II clinical trials for pancreatic cancer.

http://www.news-medical.net/.../Infinit ... ancer.aspx

Apparently this material caused quite a stir when announced at a conference earlier this year. The material is claimed to inhibit regrowth of tumour cells after treatment with Gemcitabine.

Presswatch

PressWatch
Posts: 42
Joined: Thu Mar 25, 2010 5:31 pm

Re: Innovative treatment goes into Phase II trial in US

Postby PressWatch » Tue Aug 03, 2010 10:23 am

''The scientists found.........that pancreatic cancer is resistant to chemotherapy because the tumours tend to have poor networks of blood vessels called vasculature, which makes it harder for drugs to reach the tumour.''

Tuveson now developing new testing models.

Presswatch